Wadler S - Search Results

1

High basal level gene expression of thymidine phosphorylase (platelet-derived endothelial cell growth factor) in colorectal tumors is associated with nonresponse to 5-fluorouracil.

Metzger R, Danenberg K, Leichman CG, Salonga D, Schwartz EL, Wadler S, Lenz HJ, Groshen S, Leichman L, Danenberg PV. Metzger R, et al. Among authors: wadler s. Clin Cancer Res. 1998 Oct;4(10):2371-6. Clin Cancer Res. 1998. PMID: 9796967

2

Interferon induces thymidine phosphorylase/platelet-derived endothelial cell growth factor expression in vivo.

Makower D, Wadler S, Haynes H, Schwartz EL. Makower D, et al. Among authors: wadler s. Clin Cancer Res. 1997 Jun;3(6):923-9. Clin Cancer Res. 1997. PMID: 9815767

3

Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.

Wadler S, Schwartz EL. Wadler S, et al. Cancer Res. 1990 Jun 15;50(12):3473-86. Cancer Res. 1990. PMID: 1692761 Review.

4

Chemotherapy for colorectal carcinoma: observations regarding recent clinical trials using biochemical modulation.

Wadler S, Schwartz EL. Wadler S, et al. J Clin Oncol. 1995 Oct;13(10):2676-7. doi: 10.1200/JCO.1995.13.10.2676. J Clin Oncol. 1995. PMID: 7595721 No abstract available.

5

5-Ethoxy-2'-deoxyuridine, a novel substrate for thymidine phosphorylase, potentiates the antitumor activity of 5-fluorouracil when used in combination with interferon, an inducer of thymidine phosphorylase expression.

Schwartz EL, Baptiste N, Megati S, Wadler S, Otter BA. Schwartz EL, et al. Among authors: wadler s. Cancer Res. 1995 Aug 15;55(16):3543-50. Cancer Res. 1995. PMID: 7627962

6

Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil.

Schwartz EL, Baptiste N, Wadler S, Makower D. Schwartz EL, et al. Among authors: wadler s. J Biol Chem. 1995 Aug 11;270(32):19073-7. doi: 10.1074/jbc.270.32.19073. J Biol Chem. 1995. PMID: 7642571 Free article.

7

Potentiation of the antitumor activity of 5-fluorouracil in colon carcinoma cells by the combination of interferon and deoxyribonucleosides results from complementary effects on thymidine phosphorylase.

Schwartz EL, Baptiste N, O'Connor CJ, Wadler S, Otter BA. Schwartz EL, et al. Among authors: wadler s. Cancer Res. 1994 Mar 15;54(6):1472-8. Cancer Res. 1994. PMID: 8137250

8

Modulation of 5-fluorouracil by interferon: a review of potential cellular targets.

Horowitz R, Schwartz EL, Wadler S. Horowitz R, et al. Among authors: wadler s. Med Oncol. 1995 Mar;12(1):3-8. doi: 10.1007/BF01571402. Med Oncol. 1995. PMID: 8542244 Review. No abstract available.

9

Role of interferon as a modulator of fluoropyrimidines: reply to a recent editorial.

Wadler S, Schwartz EL. Wadler S, et al. Ann Oncol. 1997 Feb;8(2):139-40; discussion 141. doi: 10.1023/a:1008202826522. Ann Oncol. 1997. PMID: 9093721 Free article. No abstract available.

10

Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.

Wadler S, Schwartz EL, Goldman M, Lyver A, Rader M, Zimmerman M, Itri L, Weinberg V, Wiernik PH. Wadler S, et al. J Clin Oncol. 1989 Dec;7(12):1769-75. doi: 10.1200/JCO.1989.7.12.1769. J Clin Oncol. 1989. PMID: 2585018

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

178 results

Search Page

Filters